Skip to main content
. 2016 Jan 11;11(1):e0146373. doi: 10.1371/journal.pone.0146373

Table 1. Bacterial strains and plasmids used in this study.

Strains/plasmids Relevant properties a Source
Escherichia coli Trans1-T1 F-φ80(lacZ)ΔM15ΔlacX74hsdR(rk-mk+recA1398endA1tonA TransGen
E. coli EC135/pM. Bam E. coli EC135 harboring pM. Bam plasmid [22]
Bacillus subtilis WB600 nprE aprE epr bpr mpr::ble nprB::bsr Ʃvpr [23]
Bacillus subtilis AS.1398 Neutral protease industrial strain This study
Bacillus amyloliquefaciens K11 Wild type strain with high neutral protease-producing capacity ACCC19735
Bacillus amyloliquefaciens 110N-6 B. amyloliquefaciens K11 harboring Bacillus sp. high copy number vector pUB110-Banpr This study
Bacillus amyloliquefaciens 110N-N3 B. amyloliquefaciens K11 harboring pUB110-Banpr vector This study
pEASY-T3 E. coli cloning vector; AmpR TransGen
pUB110 Bacillus spp. expression vector; KanR BGSC
pUB110-Banpr pUB110 harboring Banpr gene of B. amyloliquefaciens K11 This study

a AmpR, ampicillin resistance; KanR, kanamycin resistance